Myeloperoxidase inhibition with mitiperstat in heart failure with preserved or mildly reduced ejection fraction: a randomized phase 2b trial

Lars H. Lund, Carolyn S. P. Lam, Patricia Ely Pizzato, Erik Michaëlsson, Andrea Mattsson, Hans Ericsson, Malin Aurell, Anna Collen, Monika Trebski, Carl Whatling, Niklas Bergh, Andrea L. Vavere, Robin Johannes Gerardus Hartman, Alain Cohen-Solal, Chern-En Chiang, Grzegorz Drelich, Assen Goudev, Martin Hudec, Stefan Janssens, Jose Francisco Kerr Saraiva, Lars Køber, Bela Merkely, Lisa Mielniczuk, Ondrej Toman, Sandra Sanders-van Wijk, Stephan Baldus, Sanjiv J. Shah

Open source

DOI: 10.1038/s41591-026-04615-z
Published: 2026-09
Container: Nature Medicine
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41591-026-04615-z,
  title = {Myeloperoxidase inhibition with mitiperstat in heart failure with preserved or mildly reduced ejection fraction: a randomized phase 2b trial},
  author = {Lars H. Lund and Carolyn S. P. Lam and Patricia Ely Pizzato and Erik Michaëlsson and Andrea Mattsson and Hans Ericsson and Malin Aurell and Anna Collen and Monika Trebski and Carl Whatling and Niklas Bergh and Andrea L. Vavere and Robin Johannes Gerardus Hartman and Alain Cohen-Solal and Chern-En Chiang and Grzegorz Drelich and Assen Goudev and Martin Hudec and Stefan Janssens and Jose Francisco Kerr Saraiva and Lars Køber and Bela Merkely and Lisa Mielniczuk and Ondrej Toman and Sandra Sanders-van Wijk and Stephan Baldus and Sanjiv J. Shah},
  year = {2026},
  journal = {Nature Medicine},
  doi = {10.1038/s41591-026-04615-z},
  url = {https://doi.org/10.1038/s41591-026-04615-z}
}

RIS

TY  - JOUR
TI  - Myeloperoxidase inhibition with mitiperstat in heart failure with preserved or mildly reduced ejection fraction: a randomized phase 2b trial
AU  - Lars H. Lund
AU  - Carolyn S. P. Lam
AU  - Patricia Ely Pizzato
AU  - Erik Michaëlsson
AU  - Andrea Mattsson
AU  - Hans Ericsson
AU  - Malin Aurell
AU  - Anna Collen
AU  - Monika Trebski
AU  - Carl Whatling
AU  - Niklas Bergh
AU  - Andrea L. Vavere
AU  - Robin Johannes Gerardus Hartman
AU  - Alain Cohen-Solal
AU  - Chern-En Chiang
AU  - Grzegorz Drelich
AU  - Assen Goudev
AU  - Martin Hudec
AU  - Stefan Janssens
AU  - Jose Francisco Kerr Saraiva
AU  - Lars Køber
AU  - Bela Merkely
AU  - Lisa Mielniczuk
AU  - Ondrej Toman
AU  - Sandra Sanders-van Wijk
AU  - Stephan Baldus
AU  - Sanjiv J. Shah
PY  - 2026
JO  - Nature Medicine
DO  - 10.1038/s41591-026-04615-z
UR  - https://doi.org/10.1038/s41591-026-04615-z
ER  -

APA

Lund, L. H., Lam, C. S. P., Pizzato, P. E., Michaëlsson, E., Mattsson, A., Ericsson, H., Aurell, M., Collen, A., Trebski, M., Whatling, C., Bergh, N., Vavere, A. L., Hartman, R. J. G., Cohen-Solal, A., Chiang, C., Drelich, G., Goudev, A., Hudec, M., Janssens, S., Saraiva, J. F. K., Køber, L., Merkely, B., Mielniczuk, L., Toman, O., Wijk, S. S., Baldus, S., & Shah, S. J. (2026). Myeloperoxidase inhibition with mitiperstat in heart failure with preserved or mildly reduced ejection fraction: a randomized phase 2b trial. Nature Medicine. https://doi.org/10.1038/s41591-026-04615-z

Source records

crossref · retrieved 2026-09-26T04:28:20.455Z